10-Hydroxy-HHC

10-Hydroxy-HHC
Identifiers
  • (6aR,10R,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-hexhydro-6H-dibenzo[b,d]pyran-1,10-diol
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC21H32O3
Molar mass332.484 g·mol−1
3D model (JSmol)
  • CC1(C)Oc2cc(CCCCC)cc(O)c2[C@@H]2[C@@H](O)C(C)CC[C@H]21
  • InChI=1S/C21H32O3/c1-5-6-7-8-14-11-16(22)19-17(12-14)24-21(3,4)15-10-9-13(2)20(23)18(15)19/h11-13,15,18,20,22-23H,5-10H2,1-4H3/t13?,15-,18?,20+/m1/s1
  • Key:SUVXTOCRTNYFMQ-HQODNEQVSA-N

10-Hydroxy-HHC is a semi-synthetic cannabinoid which has been sold as a designer drug, first identified in Germany in December 2024.[1][2]

See also

References

  1. ^ "European Drug Report 2025 – Full Book" (PDF). European Union Drugs Agency (euda.europa.eu). 6 June 2025.
  2. ^ Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW (June 2020). "Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature". Toxics. 8 (2): 41. Bibcode:2020Toxic...8...41G. doi:10.3390/toxics8020041. PMC 7357058. PMID 32503116.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.